Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

Author(s):
Emery, P.; Burmester, G.R.; Bykerk, V.P.; Combe, B.G.; Furst, D.E.; Barre, E.; Karyekar, C.S.; Wong, D.A.; Huizinga, T.W.J. (0000-0001-7033-7520)
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2015), Vol. 74, no. 1, p. 19-26
hdl
1887/101653
doi
10.1136/annrheumdis-2014-206106